Upsher-Smith launches generic AbsoricaThe isotretinoin capsule had a market value of approximately $156 million for the 12 months ended April 2021, according to IQVIA. Hikma releases generic BanzelThe product is indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome. Cipla obtains FDA OK for generic Brovana Brovana had a market value of approximately $438 million for the 12-month period ending April 2021, according to IQVIA. Glenmark obtains FDA tentative nod for generic Ofev Glenmark has received tentative approval from the Food and Drug Administration for nintedanib capsules in dosage strengths of 100 mg and 150 mg. Hikma intros doxycycline for injection Doxycycline for injection had a market value of approximately $43 million in the 12 months ended April 2021, according to IQVIA. Alembic intros generic ProAmatine Alembic's generic ProAmatine provides a treatment for symptomatic orthostatic hypotension. Glenmark obtains FDA nod for generic Brovana Arformoterol tartrate inhalation solution is Glenmark’s first nebulizer approval. Teva debuts generic Perforomist Teva’s generic Perforomist is indicated to treat bronchoconstriction in patients with chronic obstructive pulmonary disease. Hikma rolls out Ganciclovir Ganciclovir for injection had a market value of roughly $8 million for the 12 months ended April 2021, according to IQVIA. Sun Pharma reaches patent litigation settlement for generic Revlimid Sun Pharma will be able to manufacture and sell a limited quantity of generic lenalidomide capsules after March 2022, as well as an unlimited quantity beginning Jan. 31, 2026. First Previous 113 114 115 116 117 Next Last
